Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-	-0.39	-	-0.61
Quick Ratio	14.14	0.07	0.80	0.54
Current Ratio	14.31	0.11	0.85	0.69
Return on Assets (ROA)	-	-681.04%	-232.72%	-
Buyback Yield / Dilution	-64.52%	-9.18%	-36.56%	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q